1. Abstract Submission Date: July 15, 2020 to Aug. 20, 2020.
2. The notification of abstract acceptance will be forwarded in Aug. 31, 2020. The presenting author must register at the time of abstract submission.
1. Oral Presentation (On-site, for Domestic participants only)
2. Tele-Presentation (Online, for Overseas participants only)
3. E-Poster Exhibition (Size: H 841mm×W 594mm, Straight, for Foreign)
4. Poster Exhibition (Size: H
1200~150mm x W 900mm, Straight,
EACP 2020 Guidelines for Submission
Before you begin, please prepare the following information:
Presenting author’s contact details
Full postal address
Contact phone number
Author and co-authors’ details
Full ﬁrst and family name(s)
Afﬁliation details: department, institution / organization, address/zip code, country/region
Abstract title – limited to 250 words
Abstract text – limited to 350 words
Abstract topic – select the abstract topic from the list of topics
Abstract layout – Abstracts should use the following structured format:
Material & Methods
Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content. Submissions may not contain patient names, hospital ID numbers or other identifying information. The submission form allows you to store your abstract as a DRAFT until the deadline. After the deadline, if not submitted, drafts will be deleted.
Click on the SUBMIT button at the end of the process in order to submit your abstract. Changes will not be possible to your abstract after it is submitted.
You will receive an abstract number
via email after you have submitted
your abstract. Please refer to this
abstract number in all
correspondence regarding the
Please contact us if you have not received conﬁrmation that your abstract has been submitted. Please do not submit multiple copies of the same abstract.
Rules for Submission
Please read the
submission rules before submitting
an abstract. Abstracts must be
submitted via the Abstract
Submission System only. ABSTRACTS
SUBMITTED BY EMAIL WILL NOT BE
Presentation Type: Abstracts may be submitted for Oral Communication Session, e-Poster Presentation or e-Poster Viewing.
The Scientiﬁc Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university-speciﬁc publications ofﬁce (or another similar facility) or by a copy editor, prior to submission.
Abstracts must be original and must not be or have been published or presented at any other meeting prior to the Congress.
Disclosure of Conﬂicts of Interest: Abstract Submitters will be required to disclose any conﬂict of interests in the submission form.
Upon submission, the Abstract Submitter conﬁrms that the abstract has been reviewed and that all information is correct, and accepts that the content of this abstract cannot be modiﬁed or corrected after ﬁnal submission and is aware that it will be published exactly as submitted.
Submission of the abstract constitutes the authors’ consent to publication.
Upon submission, the Abstract Submitter conﬁrms that the contact details saved in the system are those of the corresponding author, who will be notiﬁed about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.
The 12th East Asian Conference of Phonosurgery – EACP 2020 (EACP2020) Organizing Committee will review abstracts. Following the information regarding acceptance, scheduling information will be sent to the Abstract Submitter.
The EACP2020 Counsel reserves the right to withdraw any abstracts that do not meet the scientiﬁc or ethical standards of the association at any point before or after acceptance and subsequent publication in the congress abstract digital ﬂipbook.
1. New Technology
2. Imaging in laryngopharyngeal lesions
3. Big data and artificial intelligence in laryngology and phoniatrics
4. Voice outcome after thyroid and other head and neck surgeries
5. Laryngeal framework surgery
6. Swallowing rehabilitation
7. Procedures for voice disorders